Arch Biopartners, Inc. (ARCH.V)
1.07
-0.09
(-7.76%)
CAD |
TSXV |
Aug 25, 16:00
Arch Biopartners Total Liabilities (Quarterly) : 4.107M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.107M |
| December 31, 2025 | 3.624M |
| September 30, 2025 | 3.986M |
| June 30, 2025 | 3.924M |
| March 31, 2025 | 4.318M |
| December 31, 2024 | 4.794M |
| September 30, 2024 | 5.283M |
| June 30, 2024 | 8.096M |
| March 31, 2024 | 8.224M |
| December 31, 2023 | 6.350M |
| September 30, 2023 | 6.681M |
| June 30, 2023 | 7.170M |
| March 31, 2023 | 9.124M |
| December 31, 2022 | 5.187M |
| September 30, 2022 | 5.092M |
| June 30, 2022 | 5.820M |
| March 31, 2022 | 5.912M |
| December 31, 2021 | 5.559M |
| September 30, 2021 | 6.551M |
| June 30, 2021 | 7.522M |
| March 31, 2021 | 6.078M |
| December 31, 2020 | 5.533M |
| September 30, 2020 | 4.609M |
| June 30, 2020 | 4.415M |
| March 31, 2020 | 4.044M |
| Date | Value |
|---|---|
| December 31, 2019 | 3.607M |
| September 30, 2019 | 3.470M |
| June 30, 2019 | 3.235M |
| March 31, 2019 | 2.427M |
| December 31, 2018 | 2.202M |
| September 30, 2018 | 1.718M |
| June 30, 2018 | 1.661M |
| March 31, 2018 | 1.638M |
| December 31, 2017 | 1.126M |
| September 30, 2017 | 0.6313M |
| June 30, 2017 | 0.562M |
| March 31, 2017 | 0.5469M |
| December 31, 2016 | 0.5776M |
| September 30, 2016 | 0.4839M |
| June 30, 2016 | 0.4943M |
| March 31, 2016 | 0.4911M |
| December 31, 2015 | 0.4698M |
| September 30, 2015 | 0.508M |
| June 30, 2015 | 0.4116M |
| March 31, 2015 | 0.416M |
| December 31, 2014 | 0.4586M |
| September 30, 2014 | 0.4124M |
| June 30, 2014 | 0.4841M |
| March 31, 2014 | 0.4467M |
| December 31, 2013 | 0.5171M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Innovotech, Inc. | 0.9938M |
| Kane Biotech, Inc. | 3.229M |
| Quest PharmaTech, Inc. | 1.329M |
| BriaCell Therapeutics Corp. | 4.985M |
| Vaxil Bio Ltd. | 0.03M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.4632M |
| Shareholders Equity (Quarterly) | -3.644M |
| Debt to Equity Ratio | -0.7494 |
| Current Ratio | 0.1128 |
| Net Debt Paydown Yield | 0.33% |